1. Home
  2. DUO vs CLRB Comparison

DUO vs CLRB Comparison

Compare DUO & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUO

Fangdd Network Group Ltd.

N/A

Current Price

$0.54

Market Cap

24.6M

Sector

Finance

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

N/A

Current Price

$1.24

Market Cap

24.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DUO
CLRB
Founded
2011
2002
Country
China
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.6M
24.5M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
DUO
CLRB
Price
$0.54
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.50
AVG Volume (30 Days)
37.0K
★ 159.7K
Earning Date
08-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$1.12
52 Week High
$2.44
$4.70

Technical Indicators

Market Signals
Indicator
DUO
CLRB
Relative Strength Index (RSI) 42.84 39.39
Support Level $0.53 N/A
Resistance Level $0.70 $3.40
Average True Range (ATR) 0.05 0.10
MACD -0.00 0.04
Stochastic Oscillator 35.25 50.00

Price Performance

Historical Comparison
DUO
CLRB

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China. All revenues of the Group are derived from the PRC.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: